CrushSCI.com
Journal Selection & Manuscript Polishing Services
AMERICAN JOURNAL OF HEMATOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

AMERICAN JOURNAL OF HEMATOLOGY

Wiley SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
62.0Average days
49Median days
3Fastest days
236Longest days
3842025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

5 days

Current Treatment Landscape and Advances in Lymphoma in China: A Special Issue

AuthorsYuqin Song

Affiliations1. Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute Beijing China

Source PDF DOI Publisher page
154 days

Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study

AuthorsPeiqi Zhao; Yihan Wang; Min Bai; Chen Huang; Jiesong Wang; Yajun Li; Yanan Jiang; Ganggang Wang; Feng Zhu; Shu Zhao; Wei Guo; Shukai Qiao; Jianxia He; Ji Ma; Yanyan Zhang; Lei Zhu; Li Li; Wenyue Yu; Shaozhen Chen; Junqing Xu; Ou Bai; Hui Zhou; Qingyuan Zhang; Liping Su; Yuanlin Xu; Huilai Zhang

Affiliations1. Department of Lymphoma Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin Medical University Tianjin China; 2. Department of Internal Medicine Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou China; 3. Department of Hematology Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University Taiyuan China; 4. Department of Hematology The Fourth Hospital of Hebei Medical University Shijiazhuang China; 5. Department of Lymphoma & Head and Neck Oncology, College of Clinical Medicine for Oncology Fujian Medical University Fuzhou China; 6. Department of Lymphoma and Hematology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital Changsha China; 7. Department of Hematology Yantai Yuhuangding Hospital Affiliated to Qingdao University Yantai China; 8. Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital Taiyuan China; 9. Department of Hematology The Affiliated Hospital of Xuzhou Medical University Xuzhou China; 10. Department of Medical Oncology Harbin Medical University Cancer Hospital, Harbin Medical University Harbin China; 11. Department of Hematology The First Hospital of Jilin University Changchun China; 12. Department of Hematology The Second Hospital of Hebei Medical University Shijiazhuang China; 13. Department of Hematology Shanxi Provincial People's Hospital Taiyuan China; 14. Department of Hematology, Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China; 15. Nanjing Geneseeq Technology Inc. Nanjing China; 16. Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital Tianjin Medical University Tianjin China; 17. Clinical Pathology Department, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital Taiyuan China; 18. Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei China

Source PDF DOI Publisher page
21 days

Undetectable Hydroxyurea in an Untimed Blood Sample Does Not Establish Nonadherence

AuthorsZhichao Zhao; Ting Shen

Affiliations1. Department of Critical Care Medicine The Affiliated Yangming Hospital of Ningbo University Yuyao China

Source PDF DOI Publisher page
92 days

Targeted Next‐Generation Sequencing of JAK2 , CALR , and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm

AuthorsLucie Rigolot; Mathias Chea; Laetitia Largeaud; Naïs Prade; Stéphanie Dufrechou; Pauline Condom; Thomas Lhossein; Pierre‐Yves Juvin; Julie Riol; Elise Frébet; Hugo Migné; Isabelle Legoff; Carole Boivert; Barnabé Daniau; Philippe Gueudet; Pierre Bories; Françoise Huguet; Suzanne Tavitian; Eric Delabesse; Véronique De Mas

Affiliations1. Université de Toulouse, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse‐Oncopole Toulouse France; 2. Université de Montpellier, Centre Hospitalier Universitaire de Nîmes Nîmes France; 3. Centre Hospitalier de Castres Castres France; 4. Centre Hospitalier de Tarbes Tarbes France; 5. Centre Hospitalier de Montauban Montauban France; 6. Centre Hospitalier de Rodez Rodez France; 7. Centre Hospitalier d'Agen Agen France; 8. Centre Hospitalier d'Auch Auch France; 9. Centre hospitalier du Val d'Ariège Foix France; 10. Centre Hospitalier d'Albi Albi France; 11. Centre hospitalier de Cahors Cahors France; 12. Centre hospitalier de Perpignan Perpignan France

Source PDF DOI Publisher page
131 days

Monoclonal Gammopathy of Thrombotic Significance

AuthorsMatthew Ho; Saurabh Zanwar; Shaji Kumar; S. Vincent Rajkumar

Affiliations1. Division of Hematology and Oncology University of Pennsylvania Philadelphia Pennsylvania USA; 2. Division of Hematology Mayo Clinic Rochester Minnesota USA

Source PDF DOI Publisher page
11 days

Unique Aspects of Allogeneic Hematopoietic Stem Cell Transplantation in VEXAS Syndrome: One Size Does Not Fit All

AuthorsAbhishek A. Mangaonkar; Hassan B. Alkhateeb

Affiliations1. Division of Hematology, Department of Medicine Mayo Clinic Rochester Minnesota USA

Source PDF DOI Publisher page
9 days

Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations

AuthorsNardeen E. Ayad; Jacob R. Anderson; Bimalangshu Dey; Rebecca Karp Leaf; Andrew B. Song; Hanny Al‐Samkari

Affiliations1. Division of Pediatric Hematology/Oncology Washington University in St. Louis School of Medicine St. Louis Missouri USA; 2. Department of Medicine Massachusetts General Hospital Boston Massachusetts USA; 3. Division of Hematology/Oncology Beth Israel Deaconess Medical Center Boston Massachusetts USA; 4. Harvard Medical School Boston Massachusetts USA; 5. Division of Classical Hematology Mass General Brigham Cancer Institute, Massachusetts General Hospital Boston Massachusetts USA

Source PDF DOI Publisher page
6 days

Subphenotypes of Sickle Cell Disease: A Guide to Targeting Treatment?

AuthorsMartin H. Steinberg

Affiliations1. Division of Hematology and Medical Oncology Boston University Chobanian & Avedisian School of Medicine Boston Massachusetts USA

Source PDF DOI Publisher page
129 days

Identification of Clinical Sub‐Phenotypes of Sickle Cell Disease Using Latent Class Analysis

AuthorsShaina M. Willen; Ann M. Brunson; Oyebimpe O. Adesina; Ted Wun

Affiliations1. Divisions of Pulmonary Medicine and Hematology/Oncology, Department of Pediatrics University of California Davis Sacramento California USA; 2. Center for Oncology Hematology Outcomes Research and Training, Division of Hematology and Oncology University of California Davis Comprehensive Cancer Center Sacramento California USA

Source PDF DOI Publisher page
44 days

Autoantibodies to Extracellular Erythrocyte Band 3 Epitopes Are Associated With Anemia in Plasmodium vivax Infection

AuthorsAline Marzano‐Miranda; Vanessa G. Fraga; Cor Jésus F. Fontes; Simone Ladeia‐Andrade; Marcelo U. Ferreira; Daniella C. Bartholomeu; Érika M. Braga

Affiliations1. Department of Parasitology Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais Brazil; 2. School of Medical Sciences Federal University of Mato Grosso Cuiabá Mato Grosso Brazil; 3. Laboratory of Parasitic Diseases Oswaldo Cruz Institute, Fiocruz Rio de Janeiro Brazil; 4. Department of Parasitology Institute of Biomedical Sciences, University of São Paulo São Paulo Brazil

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.